Edition:
United Kingdom

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

462.10INR
11:14am BST
Change (% chg)

Rs-6.05 (-1.29%)
Prev Close
Rs468.15
Open
Rs468.15
Day's High
Rs470.00
Day's Low
Rs460.00
Volume
11,924
Avg. Vol
70,949
52-wk High
Rs617.40
52-wk Low
Rs418.90

Chart for

About

Laurus Labs Limited, formerly Laurus Labs Pvt Ltd, is an India-based research and development pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas. Its business units include... (more)

Overall

Beta: --
Market Cap(Mil.): Rs57,404.51
Shares Outstanding(Mil.): 106.03
Dividend: 1.50
Yield (%): 0.28

Financials

  LAUL.NS Industry Sector
P/E (TTM): 27.02 30.93 32.76
EPS (TTM): 20.03 -- --
ROI: -- 15.07 14.61
ROE: -- 16.60 16.34

BRIEF-Laurus Labs Says US FDA completed Unit 2 audit without observations

* Says US FDA completed audit without observations at formulations Unit 2 from Feb 26 to March 1, 2018 Source text for Eikon: (http://bit.ly/2GWa3QK) Further company coverage:

01 Mar 2018

BRIEF-India's Laurus Labs Dec-Qtr Net PAT Falls

* DEC QUARTER NET PROFIT AFTER TAX 348.7 MILLION RUPEES VERSUS PROFIT 450.2 MILLION RUPEES YEAR AGO

29 Jan 2018

Earnings vs. Estimates